DRUG · Unmapped registry intervention
Active Delta-9-THC
Find medicine records ·
Find other trials using this name
Clinical trial
In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
NCT04920539
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIn Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
Healthyunresolved
Interventions
Sponsors & collaborators
Yale Universitylead sponsor
National Institute on Drug Abuse (NIDA)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04920539 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.